Quantcast
Channel: Hologic updates from Morningstar
Browsing latest articles
Browse All 91 View Live

Hologic Posts Solid 4Q but Guides Below Expectations for 2013; Shares Remain...

Hologic HOLX posted fourth-quarter results in line with our expectations, but its conservative outlook for 2013 was disappointing. While we think the company is taking an overly conservative stance...

View Article



Hologic Kicks Off Fiscal 2013 With Solid 1Q, and We're Raising Our Fair Value...

Hologic HOLX posted fiscal first-quarter results largely in line with our expectations. We are encouraged by the strong operational performance, particularly in light of adverse conditions for capital...

View Article

Hologic to Strengthen Diagnostics Capabilities Through Gen-Probe Acquisition

Gen-Probe GPRO announced that it has received a takeover offer from Hologic HOLX for $82.75 per share, representing a total enterprise value of approximately $3.7 billion. The offer represents a 20%...

View Article

Findings From Oslo Breast Cancer Screening Trial a Key Win for Hologic

Our fair value estimate for Hologic HOLX is unchanged following the publication of favorable results from a large screening trial for the use of digital mammography combined with 3-D tomosynthesis....

View Article

Hologic Announces Sale of LIFECODES

On Thursday, Hologic HOLX announced that it has reached a final agreement to sell its LIFECODES business (acquired through the Gen-Probe transaction) to Immucor for $85 million in cash and a possible...

View Article


Hologic Reports Solid 2Q but Issues Disappointing Outlook; Plan to Lower Fair...

Hologic HOLX posted second-quarter results mostly in line with our expectations on Monday as lower-than-expected revenue was offset by solid expense management. We were encouraged by the company's...

View Article

Hologic to Buy Third Wave

On Monday, Hologic HOLX announced the acquisition of Third Wave Technologies TWTI, a developer of molecular diagnostic screens, for $580 million, or $11.25 per share. At first glance, the purchase...

View Article

Strong First Quarter Marks Hologic's Fiscal 2012 Kickoff

Hologic HOLX posted better-than-expected fiscal first-quarter operating results Monday, highlighting improved performance across all four business segments. While we are pleased with this progress, we...

View Article


Hologic Trims Guidance Again; 3D Dimensions' Prospects Rely on Favorable...

Hologic HOLX reported third-quarter results Monday that fell in line with our previous expectations, with light revenue growth and adequate expense management. The company lowered its guidance as newly...

View Article


Update on Cytyc-Hologic Merger

We anticipate the merger between Cytyc CYTC and Hologic HOLX will close as scheduled in the third quarter, despite the tightening credit environment. We're maintaining our fair value estimate for...

View Article
Browsing latest articles
Browse All 91 View Live




Latest Images